The Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPR
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
The Effect of Prebiotic Inulin on Patients Affected by R/M HNSCC Treated With Immune Checkpoint Inhibitors
- Status
- RECRUITING
- Phase
- NA
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
- Status
- RECRUITING
- Phase
- NA
HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE1
Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
3D Specimen Maps for RT Planning
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
PET/CT Follow up for Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- NA
3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial
- Status
- RECRUITING
- Phase
- PHASE2
Phase I/II Open Label Study Evaluating the Safety and Efficacy of Combining STAT3 Inhibition (TTI-101) With Anti-PD-1 Therapy (Pembrolizumab) in Patients With Recurrent or Metastatic (RM) Head and Neck Squamous Cell Carcinoma (HNSCC)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Liquid Biopsy for Early DiagNosis of Squamous Cell Carcinoma of the HeAd and NeCk rEgion
- Status
- RECRUITING
- Phase
- N/A
Study of CHS-114 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2